Rf Acquisition CORP Ii 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
RF Acquisition Corp II's Q2 2026 Form 10-Q reveals continued efforts to secure a business combination, significant cash reserves, but also substantial doubt regarding its going concern status and material internal control weaknesses.
NASDAQ
RF Acquisition Corp II reports Q1 2026 results, with net income of $93,702, driven by interest income, while continuing its search for a business combination.
NASDAQ
RF Acquisition Corp II reports Q3 2025 results, detailing a proposed merger with Nanyang Biologics and a shareholder vote to extend its business combination deadline to August 2026.
NASDAQ
10-Q: RF Acquisition Corp II Reports Q2 Net Income Amidst Going Concern Doubts and Ineffective Controls
RF Acquisition Corp II, a blank check company, reported increased net income for the second quarter of 2025 driven by trust account interest, but disclosed substantial doubt about its ability to continue as a going concern and ineffective disclosure controls.
NASDAQ
RF Acquisition Corp II reports a net income of $1.02 million for the three months ended March 31, 2025, driven by interest earned on cash held in trust.
NASDAQ
10-Q: RF Acquisition Corp II Reports Net Income of $1.4 Million for Quarter Ended September 30, 2024
RF Acquisition Corp II reported a net income of $1.4 million for the quarter ended September 30, 2024, primarily driven by interest earned on its trust account.
NASDAQ
RF Acquisition Corp II, a special purpose acquisition company, reported a net income of $486,608 for the period from February 5, 2024, through June 30, 2024, and outlined its plans to pursue a business combination in the Asian deep technology sector.
NASDAQ
RF Acquisition Corp II, a blank check company, released its first quarter 2024 financial results, detailing its formation and initial public offering activities.